(Q35170944)

6 August 2017

1 reference

title

Multiple myeloma biology: lessons from the 5TMM models (English)

1 reference

6 August 2017

1 reference

Karin Vanderkerken

1

1 reference

6 August 2017

Kewal Asosingh

series ordinal

2

1 reference

6 August 2017

Peter Croucher

series ordinal

3

1 reference

6 August 2017

Ben Van Camp

series ordinal

4

1 reference

6 August 2017

1 August 2003

1 reference

6 August 2017

Immunological Reviews

1 reference

6 August 2017

194

1 reference

6 August 2017

196-206

1 reference

The 5TMM series: a useful in vivo mouse model of human multiple myeloma

6 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Follow-up of bone lesions in an experimental multiple myeloma mouse model: description of an in vivo technique using radiography dedicated for mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

The distribution of secondary growths in cancer of the breast. 1889

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Chemokine receptor homo- or heterodimerization activates distinct signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Monocyte chemoattractant protein-1 (MCP-1), secreted by bone marrow endothelial cells, induces chemoattraction of 5T multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Laminin-1-induced migration of multiple myeloma cells involves the high-affinity 67 kD laminin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Membrane proteases: roles in tissue remodeling and tumour invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Selective in vivo growth of lymphocyte function- associated antigen-1-positive murine myeloma cells. Involvement of function-associated antigen-1-mediated homotypic cell-cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

The microenvironment of the tumour-host interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

In vivo homing and differentiation characteristics of mature (CD45-) and immature (CD45+) 5T multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

MPC-1-CD49e- immature myeloma cells include CD45+ subpopulations that can proliferate in response to IL-6 in human myelomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Myeloma isotype-switch variants in the murine 5T myeloma model: evidence that myeloma IgM and IgA expressing subclones can originate from the IgG expressing tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Upregulation of matrix metalloproteinase-9 in murine 5T33 multiple myeloma cells by interaction with bone marrow endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

7 January 2021

Lymphocyte homing and homeostasis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

7 January 2021

The matrix-degrading metalloproteinases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

7 January 2021

Neutrophil proteinases and matrix degradation. The cell biology of pericellular proteolysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

7 January 2021

Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

7 January 2021

The F-actin content of multiple myeloma cells as a measure of their migration.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

7 January 2021

Influence of treatment with APD-bisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

7 January 2021

Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

7 January 2021

The clonogenic precursor cell in multiple myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00035.X

7 January 2021

10.1034/J.1600-065X.2003.00035.X

Identifiers

DOI

1 reference

6 August 2017

1 reference